GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production
Open Access
- 2 June 2011
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (6), 1738-1747
- https://doi.org/10.1002/art.30489
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- IL-33 Induces IL-13–Dependent Cutaneous FibrosisPublished by The American Association of Immunologists ,2009
- Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: Evidence of possible gene–gene interaction and alterations in Th1/Th2 cytokinesArthritis & Rheumatism, 2009
- Basophils as T H 2‐inducing APCs: the dog can sing but is it a diva?Immunology & Cell Biology, 2009
- Therapeutic approaches for control of transcription factors in allergic diseaseJournal of Allergy and Clinical Immunology, 2008
- T cell polarization identifies distinct clinical phenotypes in scleroderma lung diseaseArthritis & Rheumatism, 2008
- Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti–topoisomerase I antibodyArthritis & Rheumatism, 2007
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJCI Insight, 2007
- Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13Proceedings of the National Academy of Sciences of the United States of America, 2007
- INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative ApproachesAnnual Review of Immunology, 1997
- Interleukin‐1, Interleukin‐2, Interleukin‐4, Interleukin‐6, Tumor Necrosis Factor α, and Interferon‐γ Levels in Sera from Patients With SclerodermaArthritis & Rheumatism, 1992